GGrantIndex
Sort

78,016 grants matching breast cancer

Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

$619,471
Beth A. Reboussin · Wake Forest University Health Sciences · U01 · FY2024 · CA

Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis

$619,467
Rebecca A Shelby · Duke University · R01 · FY2023 · CA

Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis

$619,441
Han Xiao · Rice University · R01 · FY2024 · CA

Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy

$619,436
Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2023 · HL

Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers

$619,410
Anant Madabhushi · Case Western Reserve University · R01 · FY2019 · CA

Software to facilitate multimode, multiscale fused data for Pathology and Radiolo

$619,383
Michael D Feldman · University Of Pennsylvania · R01 · FY2012 · CA

Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab

$619,306
Edith A Perez · Mayo Clinic Jacksonville · R01 · FY2011 · CA

A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC

$619,304
Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2013 · CA

CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy

$619,294
Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA

Uncovering the Molecular Determinants of Metastatic Recurrence and Impaired NK Cell Function

$619,279
Srinivas Malladi · Ut Southwestern Medical Center · R01 · FY2024 · CA

An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks

$619,249
Lana X Garmire · University Of Hawaii At Manoa · R01 · FY2018 · HD

Inflammation and Colorectal Neoplasia

$619,243
Andrew T Chan · Massachusetts General Hospital · R01 · FY2019 · CA

Testing scalable communication modalities for returning breast cancer genetic research results to African American women

$619,206
Catharine Wang · Boston University Medical Campus · R01 · FY2022 · MD

Influence of Exercise on Neurocognitive Function in Breast Cancer

$619,121
Catherine M Bender · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

ROLE OF P53-DEFICIENCY IN BRCA1-ASSOCIATED BASAL-LIKE BREAST CANCER INITIATION

$619,110
Brigham & Womens Hospital Inc · · FY2018 · Department of the Army

Defining the role of BARD1 in nucleosomal ubiquitylation

$619,105
Rachel E. Klevit · University Of Washington · R01 · FY2021 · CA

Modulating growth, progression and metastasis in breast cancer by inhibiting MDA-9

$619,098
Paul B Fisher · Virginia Commonwealth University · R01 · FY2025 · CA

NOX family NADPH oxidases: roles in innate immunity and inflammatory disease

$619,098
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

DNA Sequencing and Digital Gene Expression Core

$619,049
Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

Machine learning drives translational research from drug interactions to pharmacogenetics

$619,022
Lang Li · Ohio State University · R01 · FY2024 · LM

Cbl Proteins as Regulators of Tyrosine Kinase Signaling

$619,015
Stanley Lipkowitz · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Implementing Cancer Prevention Using Patient - Provider Clinical Decision Support

$618,984
Thomas Edward Elliott · Healthpartners Institute · R01 · FY2017 · CA

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$618,976
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA

Single cell characterization of the biomaterial immune and stromal response

$618,965
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2020 · EB

Adapting and implementing evidence-based breast cancer follow-up in primary care

$618,957
Shawna V. Hudson · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA